Table 1.
Target gene | Position of target editing residue (A) | a Num of mRNA molecules per cell | bNum of G+C/total | c RNA editing efficiency |
---|---|---|---|---|
tdh1 | 79 | 560 | 23/65 | 59%, 50% |
act1 | 1566 | 180 | 19/65 | 19%, 12% |
mel1 | 921 | 0.069 | 26/65 | 13%, 10% |
ade6 | 1160 | 9.8 | 27/65 | 10%, 8% |
ade6 | 1003 | 9.8 | 24/65 | 8%, 7% |
ade6 | 622 | 9.8 | 28/65 | Not detected |
erp5 | 672 | 6.8 | 30/65 | 14%, 12% |
mug45 | 530 | 0.24 | 26/65 | Not detected |
nmt1 | 648 | 340 | 25/65 | Not detected |
*crRNA–pRNA construct was designed for each target with derived optimal settings, i.e. pRNA with a length of 37 bp, and editing site located in pRNA region 6 bp away from crRNA–pRNA boundary. They were placed in the same plasmid (under rrk1 promoter) as described (Figure 2B).
bWithin 65 bp flanking sequence of editing residue.
cDetected by Sanger sequencing (‘Materials and Methods’ section and Supplementary Figure S2).